Evidence map›Paper›PMID 24747986›Full record

ArticlePloS one2014

Amoebal endosymbiont Neochlamydia genome sequence illuminates the bacterial role in the defense of the host amoebae against Legionella pneumophila.

Kasumi Ishida, Tsuyoshi Sekizuka, Kyoko Hayashida, Junji Matsuo, Fumihiko Takeuchi, Makoto Kuroda, Shinji Nakamura, Tomohiro Yamazaki, Mitsutaka Yoshida, Kaori Takahashi and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Influence of Copper Dose onACS ES&T water · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Complexities of Inferring Symbiont Function:Applied and environmental microbiology · 2022
    Article
  8. Article
  9. Draft Genome Sequences ofMicrobiology resource announcements · 2020
    Article
  10. PeculiarFrontiers in microbiology · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. From Many Hosts, One Accidental Pathogen: The Diverse Protozoan Hosts ofFrontiers in cellular and infection microbiology · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Kasumi IshidaDepartment of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.
Tsuyoshi SekizukaPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Kyoko HayashidaResearch Center for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan.
Junji MatsuoDepartment of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.
Fumihiko TakeuchiPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Makoto KurodaPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Shinji NakamuraDivision of Biomedical Imaging Research, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Tomohiro YamazakiDepartment of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.
Mitsutaka YoshidaDivision of Ultrastructural Research, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kaori TakahashiDivision of Ultrastructural Research, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hiroki NagaiResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Chihiro SugimotoResearch Center for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan.
Hiroyuki YamaguchiDepartment of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.
Hokkaido University · JPJuntendo University · JPNational Institute of Infectious Diseases · JPOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous work has shown that the obligate intracellular amoebal endosymbiont Neochlamydia S13, an environmental chlamydia strain, has an amoebal infection rate of 100%, but does not cause amoebal lysis and lacks transferability to other host amoebae. The underlying mechanism for these observations remains unknown. In this study, we found that the host amoeba could completely evade Legionella infection. The draft genome sequence of Neochlamydia S13 revealed several defects in essential metabolic pathways, as well as unique molecules with leucine-rich repeats (LRRs) and ankyrin domains, responsible for protein-protein interaction. Neochlamydia S13 lacked an intact tricarboxylic acid cycle and had an incomplete respiratory chain. ADP/ATP translocases, ATP-binding cassette transporters, and secretion systems (types II and III) were well conserved, but no type IV secretion system was found. The number of outer membrane proteins (OmcB, PomS, 76-kDa protein, and OmpW) was limited. Interestingly, genes predicting unique proteins with LRRs (30 genes) or ankyrin domains (one gene) were identified. Furthermore, 33 transposases were found, possibly explaining the drastic genome modification. Taken together, the genomic features of Neochlamydia S13 explain the intimate interaction with the host amoeba to compensate for bacterial metabolic defects, and illuminate the role of the endosymbiont in the defense of the host amoebae against Legionella infection.

Indexed as

Genome, BacterialSymbiosisAmoebaChlamydiaLegionella pneumophilaMolecular Sequence Data

Identifiers

PMID24747986
PMCPMC3991601
OpenAlexW2030612452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.